Bain Capital Life Sciences Investors, LLC

Q4 2017 13F Holdings Report, Stock Holdings

Signature - Title
Adam Koppel - Managing Dir. of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Holdings as of
31 Dec 2017
Value $
$152,407,000
Num holdings
3
Filing time
14 Feb 2018, 07:21:50 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included DRNA, IFRX, and MRNS.
Next filing
Q1 2018 - 15 May 2018
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Adam Koppel Managing Dir. of Bain Capital Life Sciences Investors, LLC Boston, Massachusetts 14 Feb 2018

Bain Capital Life Sciences Investors, LLC is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of Bain Capital Life Sciences Fund, L.P.

Other Included Managers (2):

Num Name Location File Number
1 Bain Capital Life Sciences Partners, LP Boston, MA
2 Bain Capital Life Sciences Fund, L.P. Boston, MA